Penetration of ofloxacin into bronchial secretions
- PMID: 3481325
- DOI: 10.2165/00003495-198700341-00008
Penetration of ofloxacin into bronchial secretions
Abstract
The penetration of ofloxacin into bronchial secretions was evaluated in 16 patients after administration of a single oral dose of ofloxacin 400mg. Bronchial secretions were aspirated at bronchoscopy after 1 to 6 hours and serum was collected simultaneously. Ofloxacin concentrations were measured by a microbiological assay method. Considerable individual variations in serum and bronchial aspirate concentrations were recorded: bronchial aspirate concentrations varied between 1.1 mg/L and 4.5 mg/L but exceeded 1.5 mg/L in 14 of 16 patients between 1 and 6 hours. The ratio between simultaneous mean bronchial aspirate and serum concentrations ranged between 0.53 in the second hour and 0.92 in the fourth hour. It is likely that inhibitory activity will be sustained over at least 6 hours against most potential respiratory pathogens including Haemophilus influenzae, Branhamella catarrhalis, Gram-negative bacilli, Staphylococcus aureus, Legionella pneumophila and Mycoplasma pneumoniae. Streptococcus pneumoniae and Pseudomonas aeruginosa may have minimal inhibitory concentration (MIC) values lower than ofloxacin concentrations achieved in bronchial secretions, although some isolates are less sensitive. Clinical studies should establish the relevance of pharmacokinetic data to respiratory infections caused by organisms of borderline susceptibility.
Similar articles
-
Ofloxacin concentrations in tissues involved in respiratory tract infections.J Antimicrob Chemother. 1990 Nov;26 Suppl D:55-60. doi: 10.1093/jac/26.suppl_d.55. J Antimicrob Chemother. 1990. PMID: 2286591 Review.
-
The penetration of ofloxacin into bronchial secretions.J Antimicrob Chemother. 1988 Sep;22 Suppl C:91-5. doi: 10.1093/jac/22.supplement_c.91. J Antimicrob Chemother. 1988. PMID: 3182469
-
Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.Am J Med. 1992 Apr 6;92(4A):8S-11S. doi: 10.1016/0002-9343(92)90299-q. Am J Med. 1992. PMID: 1316076 Clinical Trial.
-
[Diffusion of an orally administered single dose of ofloxacin into human bronchial mucus].Pathol Biol (Paris). 1986 May;34(5):353-6. Pathol Biol (Paris). 1986. PMID: 3534705 French.
-
Respiratory tract penetration of quinolone antimicrobials: a case in study.Pharmacotherapy. 1991;11(1):38-49. Pharmacotherapy. 1991. PMID: 2020610 Review.
Cited by
-
Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.Drugs. 1988 Aug;36(2):193-228. doi: 10.2165/00003495-198836020-00004. Drugs. 1988. PMID: 3053126 Review.
-
Intraoperative concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue.Antimicrob Agents Chemother. 1990 Dec;34(12):2354-7. doi: 10.1128/AAC.34.12.2354. Antimicrob Agents Chemother. 1990. PMID: 2088189 Free PMC article. Clinical Trial.
-
Haemophilus influenzae type b conjugate vaccines.Immunology. 2004 Oct;113(2):163-74. doi: 10.1111/j.1365-2567.2004.01971.x. Immunology. 2004. PMID: 15379976 Free PMC article. Review.
-
Ofloxacin clinical pharmacokinetics.Clin Pharmacokinet. 1992 Jan;22(1):32-46. doi: 10.2165/00003088-199222010-00004. Clin Pharmacokinet. 1992. PMID: 1559306 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources